Innovations in the systemic therapy of prostate cancer

被引:0
|
作者
Dale R. Shepard
Derek Raghavan
机构
[1] Taussig Cancer Institute,Department of Solid Tumor Oncology
[2] Cleveland Clinic,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Important innovations have been achieved in the development of novel systemic hormonal therapies for the salvage treatment of metastatic castrate-resistant disease. The use of chemotherapy as an adjunct for the treatment of castrate-resistant metastatic disease and local advanced tumors has also resulted in patterns of late toxic effects. The authors review the important advances in the evolution of systemic therapy for the treatment of prostate cancer.
引用
收藏
页码:13 / 21
页数:8
相关论文
共 50 条
  • [41] Systemic vasculitis and cancer of the prostate
    Egea, JJ
    Rivera, F
    Olivares, J
    Jimenez, MJ
    NEFROLOGIA, 1998, 18 (01): : 103 - 104
  • [42] Prostate Cancer Cost-effectiveness of Prostate Cancer Diagnostics: Exploring new Innovations
    Kunde, Katharina
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2022, 27 (02): : 68 - 69
  • [43] Oligometastatic prostate cancer: definition and the role of local and systemic therapy: a narrative review
    Mahjoub, Samy
    Heidenreich, Axel
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (07) : 3167 - 3175
  • [44] Current Systemic Therapy in Men with Metastatic Castration-Sensitive Prostate Cancer
    Grisay, Guillaume
    Lavaud, Pernelle
    Fizazi, Karim
    CURRENT ONCOLOGY REPORTS, 2024, 26 (05) : 488 - 495
  • [45] Mechanisms of resistance to systemic therapy in metastatic castration-resistant prostate cancer
    Galletti, Giuseppe
    Leach, Benjamin I.
    Lam, Linda
    Tagawa, Scott T.
    CANCER TREATMENT REVIEWS, 2017, 57 : 16 - 27
  • [46] MULTIMODAL SYSTEMIC THERAPY WITH DEFINITIVE PROSTATECTOMY IN DE NOVO METASTATIC PROSTATE CANCER
    Narayanan, Ramkishen
    Linehan, Jennifer
    Vogelzang, Nicholas
    Matsuba, Chikako
    Twardowski, Przemyslaw
    Wilson, Timothy
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1195 - E1196
  • [47] Contemporary Systemic Therapy Intensification for Prostate Cancer: A Review for General Practitioners in Oncology
    Batra, Anupam
    Glick, Daniel
    Valdes, Mario
    CURRENT ONCOLOGY, 2024, 31 (02) : 1047 - 1062
  • [48] Navigating systemic therapy for metastatic castration-naïve prostate cancer
    E. M. Kwan
    I. A. Thangasamy
    J. Teh
    O. Alghazo
    N. J. Sathianathen
    N. Lawrentschuk
    A. A. Azad
    World Journal of Urology, 2021, 39 : 339 - 348
  • [49] Second-Line Systemic Therapy for Highly Aggressive Neuroendocrine Prostate Cancer
    Fujimoto, Naohiro
    Tsubonuma, Yuto
    Nagata, Yujiro
    Minato, Akinori
    Tomisaki, Ikko
    Harada, Kenichi
    Miyamoto, Hiroshi
    ANTICANCER RESEARCH, 2023, 43 (09) : 3841 - 3847
  • [50] Targeted alpha therapy in a systemic mouse model of prostate cancer - a feasibility study
    Stuparu, Andreea D.
    Meyer, Catherine A. L.
    Evans-Axelsson, Susan L.
    Luckerath, Katharina
    Wei, Liu H.
    Kim, Woosuk
    Poddar, Soumya
    Mona, Christine E.
    Dahlbom, Magnus
    Girgis, Mark D.
    Radu, Caius G.
    Czernin, Johannes
    Slavik, Roger
    THERANOSTICS, 2020, 10 (06): : 2612 - 2620